Cargando…

Toll-Like Receptor 4 Activation in Cancer Progression and Therapy

Cancer immunotherapy has been the focus of intense research since the late 19th century when Coley observed that bacterial components can contribute to cancer regression by eliciting an antitumor immune response. Successful activation and maturation of tumor-specific immune cells is now known to be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oblak, Alja, Jerala, Roman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3216292/ https://www.ncbi.nlm.nih.gov/pubmed/22110526 http://dx.doi.org/10.1155/2011/609579

Ejemplares similares

Species-Specific Activation of TLR4 by Hypoacylated Endotoxins Governed by Residues 82 and 122 of MD-2
por: Oblak, Alja, et al.
Publicado: (2014)

MD-2 Determinants of Nickel and Cobalt-Mediated Activation of Human TLR4
por: Oblak, Alja, et al.
Publicado: (2015)

Development of αGlcN(1↔1)αMan-Based Lipid A Mimetics as a Novel Class of Potent Toll-like Receptor 4 Agonists
por: Adanitsch, Florian, et al.
Publicado: (2014)

The role of the C-terminal D0 domain of flagellin in activation of Toll like receptor 5
por: Forstnerič, Vida, et al.
Publicado: (2017)

Distinctive Recognition of Flagellin by Human and Mouse Toll-Like Receptor 5
por: Forstnerič, Vida, et al.
Publicado: (2016)

Short single-stranded DNA degradation products augment the activation of Toll-like receptor 9
por: Pohar, Jelka, et al.
Publicado: (2017)

Phosphodiester backbone of the CpG motif within immunostimulatory oligodeoxynucleotides augments activation of Toll-like receptor 9
por: Pohar, Jelka, et al.
Publicado: (2017)

The application of Toll like receptors for cancer therapy
por: So, Eui Young, et al.
Publicado: (2010)

Vanadate from Air Pollutant Inhibits Hrs-Dependent Endosome Fusion and Augments Responsiveness to Toll-Like Receptors
por: Zelnikar, Mojca, et al.
Publicado: (2014)

Toll-like receptor 4 in atherosclerosis
por: Li, Hongli, et al.
Publicado: (2007)

Toll-Like Receptor 9 Agonists for Cancer Therapy
por: Melisi, Davide, et al.
Publicado: (2014)

Publisher Correction: Phosphodiester backbone of the CpG motif within immunostimulatory oligodeoxynucleotides augments activation of Toll-like receptor 9
por: Pohar, Jelka, et al.
Publicado: (2018)

Publisher Correction: Phosphodiester backbone of the CpG motif within immunostimulatory oligodeoxynucleotides augments activation of Toll-like receptor 9
por: Pohar, Jelka, et al.
Publicado: (2018)

Conformationally Constrained Lipid A Mimetics for Exploration of Structural Basis of TLR4/MD-2 Activation by Lipopolysaccharide
por: Artner, Daniel, et al.
Publicado: (2013)

Toll-Like Receptors (TLRs): The Role in Tumor Progression
por: Shcheblyakov, D.V., et al.
Publicado: (2010)

Roles of toll-like receptors: From inflammation to lung cancer progression
por: Gu, Jinjing, et al.
Publicado: (2018)

Microbial-Derived Toll-like Receptor Agonism in Cancer Treatment and Progression
por: Giurini, Eileena F., et al.
Publicado: (2022)

Natural Products with Toll-Like Receptor 4 Antagonist Activity
por: Molteni, Monica, et al.
Publicado: (2018)

Trial Watch: Toll-like receptor agonists for cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

Toll-Like Receptor 3 in Solid Cancer and Therapy Resistance
por: Muresan, Ximena Maria, et al.
Publicado: (2020)

Links between Toll-like receptor 4 and breast cancer
por: Ahmed, Abubakr, et al.
Publicado: (2013)

Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma
por: Xun, Yang, et al.
Publicado: (2021)

The Role of Toll-Like Receptor Signaling in the Progression of Heart Failure
por: Yu, Lili, et al.
Publicado: (2018)

Trial Watch: Experimental Toll-like receptor agonists for cancer therapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2012)

Toll‑like receptor 3 ligands for breast cancer therapies (Review)
por: Butkowsky, Carly, et al.
Publicado: (2023)

The role of toll-like receptor 4 in tumor microenvironment
por: Li, Jing, et al.
Publicado: (2017)

Computational Approaches to Toll-Like Receptor 4 Modulation
por: Billod, Jean-Marc, et al.
Publicado: (2016)

Toll-like Receptor 4 in Acute Kidney Injury
por: Vallés, Patricia G., et al.
Publicado: (2023)

Ulvan Activates Chicken Heterophils and Monocytes Through Toll-Like Receptor 2 and Toll-Like Receptor 4
por: Guriec, Nathalie, et al.
Publicado: (2018)

Toll-Like Receptor 9 Agonists in Cancer
por: Karapetyan, Lilit, et al.
Publicado: (2020)

Toll-Like Receptors in Atherosclerosis
por: Falck-Hansen, Mika, et al.
Publicado: (2013)

Toll-like Receptors and Thrombopoiesis
por: Tang, Xiaoqin, et al.
Publicado: (2023)

Toll-Like Receptors in Secondary Obstructive Cholangiopathy
por: Miranda-Díaz, A. G., et al.
Publicado: (2011)

Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2012)

The Prognostic Role and Significance of Dll4 and Toll-like Receptors in Cancer Development
por: Fasoulakis, Zacharias, et al.
Publicado: (2022)

Expression and activation of toll-like receptor 3 and toll-like receptor 4 on human corneal epithelial and conjunctival fibroblasts
por: Erdinest, Nir, et al.
Publicado: (2014)

Role of Toll-like Receptors in Adjuvant-Augmented Immune Therapies
por: Seya, Tsukasa, et al.
Publicado: (2006)

Emerging role of Toll-like receptor 4 in hepatocellular carcinoma
por: Yang, Jing, et al.
Publicado: (2015)

The emerging role of Toll-like receptor 4 in myocardial inflammation
por: Yang, Y, et al.
Publicado: (2016)

Obesity, Inflammation, Toll-Like Receptor 4 and Fatty Acids
por: Rogero, Marcelo Macedo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fr2e724g6okl92fa5o67g5qjc2